References automatically added to CGD since 2026-01-26 (possibly not yet curated) |
|---|
| Reference | Species | Genes Addressed |
|---|
Belgacem S, et al. (2026) In vitro Susceptibilities to caspofungin of Candida spp. isolated from the Polyvalent Intensive Care Unit of Fattouma Bourguiba University Hospital: First report of resistant mutants in Tunisia. J Mycol Med 36(1):101601
| C. glabrata | |FKS1 |
| C. albicans | |GSC1 |GSL1 |
Bolsenbroek A, et al. (2026) The role of OLE2 and POX1-3 in prostaglandin E(2) production and virulence is conserved in Candidozyma (Candida) auris. Microbiol Spectr :e0232325
| C. albicans | |OLE2 |POX1 |POX1-3 |
| C. dubliniensis | |Cd36_81950 |
Davis FA and O'Meara TR (2026) Microbial interactions: Crosstalk in the fungal mycobiome through a novel small protein. Curr Biol 36(1):R25-R27
| C. glabrata | |YHI1 |
Davis FA, et al. (2026) Bacterial metabolites induce cell wall remodeling, antifungal resistance, and immune recognition of commensal fungi. Curr Biol
| C. albicans | |SLN1 |
Elekhnawy E, et al. (2026) Antifungal activity of oily core PEGylated PLGA nanocapsules loaded with Penicillium oxalicum fungal extract: in vitro, in vivo, and in silico study. Microb Cell Fact
| C. albicans | |SAP4 |
Hou J and Li M (2026) MiR-210 suppresses Candida albicans-derived beta-glucan-induced inflammation in THP-1-derived macrophages via the Syk-NF-kappaB pathway. Immunobiology 231(1):153156
| C. albicans | |C1_11910W_A |
Jayasekara LACB, et al. (2026) Overcoming Candida albicans biofilm drug resistance via azole-sophorolipid synergy. Sci Rep
| C. albicans | |BCR1 |CDC28 |EFG1 |
Khan N and Faryal R (2026) Emerging role of Candida species virulence factors and antifungal resistance in ureteral stent colonization and encrustation. Acta Trop 274:107979
| C. albicans | |ALS1 |ERG11 |HWP1 |
Lanser DM, et al. (2026) Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model. PLoS One 21(1):e0340202
| C. albicans | |RPN11 |
Lee S, et al. (2026) Genomic Insights into Candidozyma auris Clade II: Comparative Phylogenomics and Structural Validation of Fluconazole Resistance Mechanisms. J Fungi (Basel) 12(1)
| C. auris | |TAC1b |
Lok B, et al. (2026) Gene expression profiling of the carbon pathways and virulence factors of Candida albicans in different carbon sources. Microb Pathog 212:108311
| C. albicans | |ICL1 |MDH1 |MDH1-1 |MLS1 |
Lortal L, et al. (2026) Candida albicans-induced ubiquitination of EGFR reveals novel host-fungal interaction pathways. mBio :e0344825
| C. albicans | |ALS3 |ECE1 |
Ma S-J, et al. (2026) Non-receptor tyrosine kinase c-Abl downstream of C-type lectin receptors regulates innate antifungal immunity through c-Cbl/MAPK pathway. Infect Immun :e0036525
| C. albicans | |CEK1 |
Martinez M, et al. (2026) C. elegans as a tractable infection model for the emerging fungal pathogen Candida auris. Microbiol Spectr :e0315625
| C. albicans | |ADE2 |
Mundhe AK, et al. (2026) In silico screening of IMPPAT-derived phytochemicals targeting ERG6 and drug resistance-associated proteins in drug-resistant Candida albicans: virtual screening and molecular dynamics using alphafold models. In Silico Pharmacol 14(1):30
| C. albicans | |CDR1 |CDR11 |CDR2 |CLB2 |ERG1 |ERG11 |ERG6 |
Neves BR, et al. (2026) Adherence assessment of Candida albicans on CAD/CAM and conventional resin for denture base: A systematic review and network meta-analysis. J Prosthodont Res
| C. albicans | |ADH1 |
Nouayti FZ, et al. (2026) Synthesis, Characterization, Density Functional Theory Calculation, In Silico and In Vitro Antimicrobial Evaluation of New 1,2,4-Triazole-Amide Conjugates. Chem Biodivers 23(1):e03349
| C. albicans | |CYP5 |ERG11 |
O'Connor-Moneley J, et al. (2026) Depletion of the Candida albicans TLO gene family reveals a requirement for alpha TLO genes for wild-type virulence. Microbiology (Reading) 172(1)
| C. albicans | |CTA26 |TLO5 |
Pedras A, et al. (2026) The siderophore transporter Sit1 is involved in the uptake of caspofungin by Candida albicans. Antimicrob Agents Chemother :e0123625
| C. albicans | |SIT1 |
Piraine REA, et al. (2026) Fungal extracellular vesicles mediate conserved cross-species communication and immunomodulation. mBio :e0346925
| C. auris | |ERG11 |
| C. albicans | |ERG11 |LAC1 |
Sadiq GM, et al. (2026) Phenylpiperazine/dithioates as novel H(2)S donors: design, synthesis, H(2)S release, formulation as PEG-niosomes and antifungal activity against Candida albicans. Bioorg Chem 170:109494
| C. albicans | |CYP5 |ERG11 |
Spera AM, et al. (2026) Nine-Year Surveillance of Candida Bloodstream Infections in a Southern Italian Tertiary Hospital: Species Distribution, Antifungal Resistance, and Stewardship Implications. J Pers Med 16(1)
| C. albicans | |C1_14510C_A |C4_03220C_A |C4_03260C_A |C7_04350C_A |
Sze JLJ, et al. (2026) Fungal Reactive Oxygen Species Secreted by Candida albicans Induce Barrier Disruption and Cell Death in HaCaT Keratinocytes. J Fungi (Basel) 12(1)
| C. albicans | |C1_11020W_A |CFL11 |
Toth Hervay N, et al. (2026) Catechin Augments the Antifungal Efficacy of Fluconazole Against Candida parapsilosis. Int J Mol Sci 27(2)
| C. parapsilosis | |CDR1B |TAC1 |
Tuan DA and Masak J (2026) Ocimum gratissimum (Linnaeus) essential oil disrupts Candida albicans biofilms via morphogenetic suppression and stress reprogramming: translational implications for antifungal prophylaxis. Biofouling :1-14
| C. albicans | |ALS3 |BCR1 |CSR1 |EFG1 |GSC1 |GSL1 |HSP90 |HWP1 |SOD5 |
Wang Y (2026) Mechanistic insights into Gwt1-substrate interactions and antifungal drug discovery via molecular dynamics and virtual screening. J Biomol Struct Dyn :1-9
| C. albicans | |GWT1 |
Wei Y and Mao X (2026) Vacuole and mitochondria patch (vCLAMP) protein Mcp1 reduces the pathogenesis of Candida albicans by impeding the function of Cap1-mediated oxidative stress response. BMC Microbiol
| C. albicans | |CAP1 |GLR1 |MCP1 |SOD2 |SRV2 |TRR1 |
Wei Y, et al. (2026) Candida albicans Extracellular Vesicles Upregulate Nrg1 Transcription Repressor to Inhibit Self-Hyphal Development and Candidemia. Int J Mol Sci 27(1)
| C. albicans | |BRG1 |C3_06690C_A |NRG1 |SKO1 |
Wei Y, et al. (2026) Controllable Engineered Probiotic Hydrogel Coatings Prevent Drainage Tube-Associated Infections by Disrupting Pathogen Oxidative Stress Responses. Adv Healthc Mater :e05654
| C. albicans | |ARO10 |
Zabad G, et al. (2026) Antifungal efficacy of Miswak extracts versus sodium hypochlorite against Candida albicans on CAD-CAM denture base: an in-vitro study. BMC Complement Med Ther
| C. albicans | |ADH1 |